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Background: Carcinogens in cigarette smoke can induce the formation of DNA-DNA cross-links, which are
repaired by the Fanconi anemia (FA) pathway, and it is tempting to speculate that this pathway is involved in lung
tumorigenesis. This study is to determine whether genetic polymorphism of the FA genes is associated with an
elevated risk of lung adenocarcinoma, and whether the association between genotypes and risk is modified by
exposure to cigarette smoke.
Methods: This case–control study genotyped 53 single-nucleotide polymorphisms (SNPs) in FA genes in 709 patients
(354 males and 355 females) with lung adenocarcinoma and in 726 cancer-free individuals (339 males and 387
females). Genotypic frequencies of SNPs were compared between cases and controls to identify important FA genes
associated with cancer susceptibility. Joint effects in determining cancer risk contributed by genes and smoking-related
risk factors and by multiple genes involved in different FA subpathways were evaluated by multivariate regression
analysis and stratified analysis. All analyses were performed on males and females separately, and the comparison of
results was considered a way of examining the validity of study findings.
Results: Lung adenocarcinomas in both male and female patients were associated with (a) genotypic polymorphisms
of FANCC and FANCD1; (b) a combined effect of harboring a higher number of high-risk genotypes and smoking/
passive smoking; (c) specific interactions of multiple genes, proteins encoded by which have been known to work
jointly within the FA pathway.
Conclusions: Genetic polymorphism of the FA genes is associated with inter-individual susceptibility to lung
adenocarcinoma.
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Cigarette smoking, the most important risk factor
causally linked to lung tumorigenesis, is associated
with a four-fold increase in lung cancer risk.
Although 80 % of lung cancers can be attributed to
such exposure [1, 2], only 15 % of smokers develop
lung cancer [2, 3], strongly suggesting the importance
of inter-individual genetic susceptibility in modulating* Correspondence: hmh0823@gmail.com
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of smoking is caused by attack by tobacco metabolites
on DNA to form DNA adducts.
Cytochrome P450 enzymes are responsible for the acti-
vation and detoxification of these metabolites [4] and it
has long been suggested and indeed shown that low-
penetrance polymorphic alleles of genes encoding these
enzymes are important in determining genetic susceptibil-
ity to lung cancer [4–6]. In addition to the neutralization
of carcinogens by these enzymes before they can damage
DNA, cells have developed overlapping pathways to repair
this type of damage, thus protecting genomic integrity [7].s distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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polymorphisms of DNA repair genes has been demon-
strated [8–10]. The genes involved include those involved
in the nucleotide excision repair pathway, which removes
bulky adducts, and in the base excision repair pathway,
which deals with small lesions caused by alkylating agents
or reactive oxidative species in cigarette smoke. Some
important chemicals in cigarette, e.g., 1,2,3,4-diepoxybu-
tane (DEB) [11, 12], induce formation of DNA-DNA
adducts by sequentially alkylating two nucleobases within
the DNA double helix. If left unrepaired, this cross-linking
would lead to a variety of genotoxic effects, including
point mutations, large deletions, and chromosomal aber-
rations commonly seen in lung cancer [13]. The Fanconi
anemia (FA) pathway regulates the repair of DNA cross-
linking damage [14–16], and it is tempting to speculate on
a possible lung tumorigenic role of this pathway. To test
this hypothesis, this case–control study examined whether
genetic polymorphism of FA pathway genes is associated
with an elevated risk of lung adenocarcinoma and whether
the association between genotypes and risk is modified by
exposure to cigarette smoke.
To date, eighteen FA pathway genes have been identi-
fied, germline mutation of which results in a common FA
phenotype, a rare genetic disorder characterized by aplas-
tic anemia, cancer/leukemia susceptibility, and cellular
hypersensitivity to DNA crosslinking agents [14, 17, 18].
The proteins encoded by individual FA genes form three
functional complexes (the nuclear core complex, ubiquiti-
nated complex, and repair complex), which act coopera-
tively and sequentially to repair DNA crosslinking damage
[14, 15, 19–26]. BRCA2 (FANCD1), PALB2 (FANCN),
and BRIP1 (FANCJ) interact with BRCA1 for DNA cross-
linking repair [27, 28]. Recently, the presence of biallelic
BRCA1 mutations in some patients with multiple con-
genital anomalies consistent with a FA-like disorder [28].
Based on these molecular interactions operating within
and between the individual steps of the FA pathway, our
comprehensive examination of the association between
genetic variants of all FA genes and tumorigenesis of lung
adenocarcinoma provides a unique opportunity for
exploring whether joint effects of genes coding for




We enrolled subjects who were participating in the
Genetic Epidemiological Study of Lung Adenocarcinoma
(GELAC) in Taiwan, a molecular epidemiological study on
genetic susceptibility markers for lung cancer [29, 30].
Because of the homogenous genetic background of the
Taiwanese population, its use reduces the chance of false
positives due to population stratification [31]. The studyaim of the GELAC is mainly focused on patients with lung
adenocarcinoma, as adenocarcinoma is the most common
histological type of lung cancer in Chinese women in
Taiwan [32]. Lung cancer patients, aged 18 years or older,
with histological or cytological diagnoses were recruited
from 6 tertiary medical centers in Taiwan. The study
included 354 male lung adenocarcinoma patients and 355
female lung adenocarcinoma patients, recruited between
September 2002 and December 2005. Patients with a
history of other cancers were excluded from this study.
These patients accounted for almost all (>95 %) subjects
with lung cancer attending our lung cancer clinics during
this period, the other patients being excluded because of a
lack of suitable blood specimens. No significant differ-
ences in risk factors of lung cancer were found between
the included and excluded subjects.
The control subjects were cancer-free individuals (339
males and 387 females) randomly selected from the
health examination clinics of the same hospitals during
the same period of case recruitment [29, 30]. Individuals
with a history of cancer or showing any evidence of
suspicious precancerous lesions were excluded as con-
trols. Eighty-seven percent of eligible controls agreed to
take part. The study was performed after approval by the
institutional review board of each participating institute
(National Health Research Institutes).
Questionnaire and specimen collection
At recruitment, trained research nurses were assigned to
obtain informed consent for the collection of a blood sam-
ple and to administer a structured questionnaire. The
questionnaire collected information about demographic
characteristics, lifestyle factors (such as number of ciga-
rettes smoked), medical history, and family history of can-
cer. In terms of smoking status, a person who was
currently smoking at least one cigarette a day and had
been doing so for more than 6 months was regarded as a
current smoker. The validity of the questionnaire has been
addressed and confirmed in our previous studies [29, 30].
SNP selection and genotyping
Genomic DNA was extracted from blood specimens
from all subjects using the conventional salting-out
procedure. In this study, in addition to the size of the
genes and a >5 % minor allele frequency of SNPs, the
haplotype block structure of individual FA genes was
used to select SNPs. All SNPs were chosen based on the
information for the Chinese population in the HapMap
database (Additional file 1: Figure S1) [33]. In theory, for
SNPs that are in strong linkage (i.e., linkage disequilib-
rium, LD), a limited number of tag SNPs is enough to
reflect the polymorphic status of the gene. We followed
this principle to choose SNPs, ensuring that at least one
SNP was selected for each haplotype block of each FA
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not included in this study because it is located on the X
chromosome, which suggests than any association would
be less in male lung cancer patients than in females,
and, more importantly, no SNP in FANCB has yet been
found in the Chinese population. A genotyping platform
based on the 5′ nuclease allelic discrimination TaqMan
assay in a 96-well format on an ABI Prism 7900HT
Sequence Detection System (Applied Biosystems) was
used for genotyping. In an initial screening of 96 cases
and 96 controls, all 65 SNPs were genotyped. Of these,
12 were not observed or were infrequent (frequency of
the minor allele < 0.01), so these SNPs were not geno-
typed in the rest of the samples. The remaining 53 SNPs
(Fig. 1) were genotyped in all cases and controls. The
representativeness of these selected SNPs is supported
by the results of genotyping in our controls, showingFig. 1 Schematic diagram of the Fanconi anemia (FA) genes and locations o
genes. The length of the line representing each FA gene is proportional to th
the SNPs genotyped and analyzed in this study. The SNPs marked in orange a
those marked in light blue are significantly associated with lung adeno
FANCC) is significantly associated with lung adenocarcinoma in both mthat, in individual genes, almost all blocks of a gene were
represented by at least one SNP (Additional file 2: Figure
S2). To ensure that the observed polymorphisms were
specific and not the result of experimental variation,
10 % of the samples were randomly selected and run in
duplicate, with complete concordance of results.
Data analysis
The following sequential statistical analyses [34, 35]
were used.
(i) Univariate and multivariate analyses were used to
determine risk factors and to establish background
risk profiles for lung adenocarcinoma in this series
of study subjects. Smoking-related risk factors, i.e., a
history of cigarette smoking or passive smoking,
were used as indices to estimate the effect off the genotyped single-nucleotide polymorphism (SNPs) in individual FA
e size (i.e., base pair) of the gene. Black boxes, exons; arrows, positions of
re those significantly associated with lung adenocarcinoma in females,
carcinoma in males, and that marked in purple (i.e., rs356665 in
ales and females
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the subsequent analysis.
(ii) To ensure that the controls used were
representative of the general population and to
exclude the possibility of genotyping error, deviation
of the genotype frequencies of each SNP in the
control subjects from that expected under Hardy-
Weinberg equilibrium was assessed using the
goodness-of-fit test. The degree of LD between
markers was indicated using Lewontin’s D’ value.
(iii)Differences in genotypic frequencies of individual
SNPs between cases and controls were tested using
the chi-squared and Fisher’s exact tests. Multiple
logistic regression analysis with simultaneous
consideration of known risk factors of lung
adenocarcinoma was performed and the adjusted
odds ratios (aORs) for the associations estimated.
(iv)Because we were especially interested in the
relationship between the FA genes and lung
adenocarcinoma risk within categories of smoking-
related risk factors representing different degrees of
smoke exposure, we calculated the risk of lung
adenocarcinoma associated with the combination of
the number of putative high-risk genotypes of FA
genes and a given smoking-related risk factor. Using
ß estimates from the logistic regression model, in
which we used a set of dummy variables representing
different combinations of genes (i.e., number of
putative high-risk genotypes) and a history of smoke
exposure, we assessed the relative excess risk from
harboring higher numbers of putative high-risk
genotype within risk factor strata (the joint method
described in refs. [35] and [36].
(v) Based on the known interactions of the proteins in
the FA pathway (Additional file 1: Figure S1), we
applied a combination of the joint and stratified
methods [35, 36] to determine whether specific
known molecular interactions among FA proteins
are associated with lung adenocarcinoma
susceptibility. We therefore first stratified the
subjects on the basis of the genotypic status of the
most functionally important FA gene, as determined
in previous molecular and cellular studies, then a
joint effect of FA genes on increased lung
adenocarcinoma risk was explored using
conventional logistic regression, a test evaluating
whether a statistically significant increase in risk is
observed with specific combinations of putative high-
risk genotypes in these genes (measured by the ß
estimates from this regression model). An alternative
method would be to use the p value for interaction to
examine whether the “interaction” of two/multiple
genes is associated with cancer risk. However, this
p value is based on an assumption of a multiplicativeeffect, and, though statistically justified, this model
may not reflect the combined effects of genes coding
for proteins in the FA pathway.
Though a gender effect can be adjusted in data ana-
lysis, we deliberately performed all analyses on males
and females separately. Because they all had adenocar-
cinoma of the lung sharing common etiologies, if the FA
pathway plays a role in lung tumorigenesis, similar
results may be expected for the male and female lung
adenocarcinoma patients.
Accordingly, the comparison of results between gen-
ders can be considered a way of testing the validity of
our findings.
Results
The risk profile of this series of study subjects was simi-
lar to that reported in our previous studies [29, 30], and,
using multivariate logistic regression analysis considering
all known risk factors of lung cancer, smoking-related
risk factors were found to play a dominant role in deter-
mining lung adenocarcinoma risk. As shown in Table 1,
in males, almost 72 % of cancer patients had a history of
cigarette smoking of more than six months as compared
to 49 % in controls, resulting in a significant aOR of 1.82
[95 % confidence interval (95 % CI), 1.28–2.56]. In
addition, 85.3 % of male patients reported having been
frequently exposed to passive smoking compared to
64.9 % of controls, and this was associated with a higher
odds ratio of 2.68 (95 % CI, 1.79–4.02). In females, as
expected, due to the fact that cigarette smoking is
relative uncommon in Asian women, this putative risk
factor had no significant effect on risk. However, as in
males, a history of passive smoking was reported very
frequently in females (74.9 % of cases and 57.6 % of
controls) and was the most important risk factor,
associated with a two-fold increase (aOR, 2.13; 95 %
CI, 1.53–2.95) in risk.
All 53 SNPs were in Hardy-Weinberg equilibrium in
the controls. To obtain initial information about a
possible association between lung adenocarcinoma and
SNPs of the FA genes, the genotype distributions of
these SNPs were compared between cases and controls
in males and females separately. We estimated the risk
(aOR) associated with harboring both the homozygous
variant genotype and one additional at-risk allele, and 16
SNPs were found to show a statistically significant differ-
ence (Fig. 1). Notably, most of these were clustered
within a given gene, multiple significant SNPs being
found in FANCA, FANCC, and FANCD1 in female
patients and in FANCL in male patients. This suggests
that the association detected may not be due solely to
chance. The reliability of these associations was sup-
ported by the finding that SNPs in FANCC and FANCD1
Table 1 Distribution of risk factors of lung adenocarcinoma and adjusted odds ratios in relation to risk of lung adenocarcinoma in
males and females in Taiwan
Male Female
Risk factor No. cases (%) No. controls (%) aOR (95 % CI)a No. cases (%) No. controls (%) aOR (95 % CI)a
Cigarette smoking
> = 6 months 255(72.0) 166(49.0) 1.82(1.28–2.56) 17(4.8) 13(3.4) 1.18(0.54–2.54)
Passive smoking
Yes 302(85.3) 220(64.9) 2.68(1.79–4.02) 266(74.9) 223(57.6) 2.13(1.53–2.95)
Smoke exposure during cooking
Yes NA NA NA 319(89.9) 339(87.6) 1.05(0.66–1.68)
Using motor cycle for transport
> = 6 months 239(67.5) 157(46.3) 2.00(1.42–2.81) 165(46.5) 164(42.4) 1.34(0.95–1.92)
aaOR, adjusted odds ratio; 95 % CI, 95 % confidence interval. These were estimated in a multivariate logistic regression model, containing age, years of schooling
of study participants, and the risk factors listed in this Table
Table 2 Unconditional logistic regression analysis of genotype
polymorphisms of FA genes and multiple risk factors for lung
adenocarcinoma development
Risk factor Multivariate aORa 95 % CIa
Male lung cancer patients
FA gene
FANCC(rs356665)
AA vs. AG,GG 2.06 1.13–3.72
FANCD1(rs9634672)
TT vs. GT,GG 2.24 1.31–3.85
FANCL(rs12470316)
TT vs. CT, CC 1.78 1.02–3.13
Cigarette smoking
Yes vs. No 2.29 1.80–4.46
Passive smoking
Yes vs. No 2.83 1.79–4.46
Female lung cancer patients
FA gene
FANCC(rs4744451)
GG vs. GT,TT 1.67 1.01–2.75
FANCD1(rs9534275)
AA vs. AC,CC 1.62 1.20–2.32
FANCJ/BRIP1/BACH1(rs16945628)
CC vs. CT, TT 1.44 1.02–2.01
Passive smoking
Yes vs. No 2.14 1.50–3.03
aaOR, adjusted odds ratio; 95 % CI, 95 % confidence interval. These were
estimated in a multivariate logistic regression model, containing age and years
of schooling of study participants
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and females, consistent with the fact that the lung
cancers were all adenocarcinomas and would share a
similar molecular etiology in both sexes, such as suscep-
tibility genes. Interestingly, one SNP, rs356665, located
at the 3′-end of FANCC, was found to be significant in
both male and female lung adenocarcinoma patients.
However, in females, other SNPs in FANCC also showed
a significant association, while, in males, rs356665 was
the only significant FANCC SNP in determining risk. To
explain this, we checked the LD among SNPs, and found
that rs356665 was located in a different haplotype block
compared to other SNPs of FANCC in both males and
females (Additional file 3: Figure S3). One possibility is
that FANCC has multiple functional domains, and that, in
males, only the domain encoded by the 3′-end sequence
is important, while all domains are associated with suscep-
tibility in female lung adenocarcinoma patients.
To comprehensively assess the individual contribu-
tion of different FA genes in the association with lung
adenocarcinoma development, we performed a logistic
regression analysis considering the effects of both
environmental risk factors and individual genes simul-
taneously. As shown in Table 2, consistent with the
findings of the single SNP/gene analysis, the high-risk
FANCC and FANCD1 genotypes were strongly associ-
ated with lung adenocarcinoma risk in both males
and females. In addition, polymorphisms of FANCL
or FANCJ were associated with a relatively minor, but
still significant, risk in male or female lung adenocar-
cinomas, respectively.
If these FA genes were associated with lung adenocar-
cinoma development via the hypothesized mechanism
involving the repair of cross-linking damage caused by
smoke, the relationship between cancer risk and suscepti-
bility genotypes would be expected to be more significant
in the subset of individuals with a history of cigarette
smoking or passive smoking. We therefore investigatedthe potential importance of smoke exposure in conjunc-
tion with the three susceptibility genotypes identified in
Table 2. Our suggestion was supported by the findings
shown in Fig. 3, which showed that cigarette smoke may
modify the association between the number of high-risk
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significant association of an increased cancer risk contrib-
uted by a higher number of high-risk genotypes was seen
in males with a history of cigarette smoking and in females
with a history of passive smoking (Fig. 2). In contrast,
among individuals without a history of smoking or passive
smoking, the lung adenocarcinoma risk conferred by a
high number of high-risk genotypes was less.
No evidence was found for a role of genes of the FA
UB complex (i.e., FANCD2 and FANCI) in lung adeno-
carcinoma susceptibility. This was unexpected, because
the corresponding proteins are known to play a central
role in switching the FA DNA damage response and in
linking the FA core complex with the FA repair complex
to repair cross-linking damage [14, 20, 37, 38]. One
possible explanation is that, because the genes coding
for the UB complex are crucial in the FA pathway, any
severe defects in them would result in genomic instabil-
ity and trigger cell death by cell cycle checkpoint surveil-
lance [39]. Thus, for these high-penetrant FA genes,
only subtle defects arising from low-penetrance (risk)
alleles would escape checkpoint surveillance and allow
accumulation of the unrepaired DNA damage required
for tumor formation. As a result, only a combination of
functionally-related low-penetrance alleles would be
found to have a significant effect on cancer risk [40]. To
address this possibility, we generated a two (disease
status, i.e., case and control)-by-four (genotype status of
both FANCD2 and FANCI) table, in which individuals
with putative low-risk genotypes of both FANCD2 and
FANCI served as the reference group. When arranged in
this way, the data showed that the aOR for the putative
high-risk genotype of FANCD2 or FANCI alone was not
significant, whereas the aOR for both together wasFig. 2 Risk (adjusted odds ratio, aOR, 95 % confidence interval, 95 % CI) of
effect of harboring a higher number of putative at-risk genotypes of Fancosignificant in both males and females (Table 3), a result
consistent with a joint effect of two FA UB complex
subunits on lung adenocarcinoma risk.
Recent studies have shown that individual FA proteins
act jointly within different FA complexes (Additional file 1:
Figure S1), and there are interactions between the different
FA proteins within an individual FA complex, sequentially
affecting specific functions of DNA repair [14, 19, 20].
Thus, it was intriguing to determine whether these
interactions between FA proteins may be associated
with lung adenocarcinoma development. To this end,
we performed a stratified analysis [34]. If these FA
genes were associated with cancer via the hypothe-
sized mechanism involving the molecular interaction
of component proteins within the FA complex, the
relationship between cancer risk and susceptibility ge-
notypes would be expected to differ in cases/controls
harboring different genotypes of the most functionally
critical FA genes in specific complexes. We therefore
focused on the interactions within (a) the FA repair
complex, (b) the FANCF/C/E complex, and (c) the FA
core complex, in which genotypes of FANCJ, FANCF,
and FANCM were used as respective stratification
markers. The rationale underlying this strategy is
based on the evidence that: (a) within the FA repair
complex, FANCD1 and FANCN have been purified as
a sub-complex different from that containing FANCJ,
and each of these subcomplexes interacts with differ-
ent repair proteins and is responsible for different
steps in repairing cross-linking damage [14, 41]; (b)
FANCF acts as an adaptor protein that plays a key
role in the assembly of FANCC/E with the other FA
proteins in the FA core complex [14, 42, 43]; (c)
FANCM has ATP-dependent DNA translocase activity,lung adenocarcinoma in males and females associated with a joint
ni anemia (FA) genes and smoking or passive smoking
Table 3 Lung adenocarcinoma risk associated with the number of high-risk genotypes of FANCD2 and FANCI in male and female
lung adenocarcinoma patients-Joint effect of component genes in the FA UB complex
Genotype of No. cases (%) No. controls (%) aOR (95 % CI)a P for trend
FANCD2b FANCIb
Male lung adenocarcinoma patients
AA CC 82(27.1) 94(33.6) 1.00(ref.) 0.03
AA CC, CT 104(34.3) 94(33.6) 1.27(0.94–1.93)
AG,GG CC 50(16.5) 44(15.7)
AG,GG CC,CT 67(22.1) 48(17.1) 1.83(1.08–3.13)
Female lung adenocarcinoma patients
AA CC 42(14.1) 63(18.9) 1.00(ref.) 0.02
AA CC,CT 65(21.9) 57(17.1) 1.52(0.95–2.42)
AG,GG CC 87(29.3) 114(34.1)
AG,GG CC,CT 103(34.7) 100(29.9) 1.81(1.10–2.99)
aaOR, adjusted odds ratio; 95 %CI, 95 % confidence interval. These were estimated in a multivariate logistic regression model, containing age, years of schooling
of study participants, and the smoking-related risk factors (i.e., cigarette smoking and passive smoking) identified in Table 2
bThe SNPs used in the analysis were rs6792811 (FANCD2) and rs9806604(FANCI) in males and rs6792811(FANCD2) and rs9920768(FANCI) in females
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complex along DNA to the damage site [14, 44, 45]. The
results shown in Fig. 3 are consistent, in both males (A)
and females (B), with combined effects of component FA
genes in determining cancer risk. Using the interaction
between FANCM and other component genes in the FA
complex as an example (right side of Fig. 3), a significant
increasing trend (P < 0.05) in lung adenocarcinoma risk
associated with a higher number of high-risk genotypes of
the component genes within the FA core complex was
only seen in individuals with the putative high-risk geno-
type of FANCM. Similar patterns were observed in the
other two interactions (left side of Fig. 3), a significant
increasing trend (P < 0.05) associated with FANCD1/N or
FANCC/E only being found in the strata of specific geno-
types of FANCJ or FANCF, respectively. The possibility of
a difference in statistical power in the detection of cancer
risk due to different sample sizes in the subsets of study
subjects can be excluded, as there were actually fewer
study subjects in the strata showing significant P values. It
is notable that both female and male lung adenocarcinoma
patients gave the same results.
Discussion
Based on a multigenic model and known molecular
interactions between proteins involved in DNA repair
mechanism and using an epidemiologic approach, the
present study examined the contribution to lung tumori-
genesis of the genes encoding the proteins in the FA
pathway, the key mechanism involved in repairing DNA
cross-linking damage. This study addressed not only the
lung tumorigenic risk associated with the FA genes, but
also whether there is a combined effect of these genes
and cigarette smoke in relation to lung adenocarcinoma
development and whether a joint effect of componentFA genes within different FA complexes is important in
determining cancer risk. Support for the role of genetic
polymorphism of the FA genes associated with inter-
individual susceptibility to lung adenocarcinoma came
from the combination of three lines of evidence; Lung
adenocarcinomas in both male and female patients were
consistently associated with (a) genotypic polymor-
phisms of FANCC and FANCD1; (b) a combined effect
of harboring a higher number of high-risk genotypes
and smoking/passive smoking; (c) specific interactions of
multiple genes, proteins encoded by which have been
known to work jointly within the FA pathway. Our study
permits a more precise and comprehensive evaluation of
the lung adenocarcinoma risk associated with FA genes
and a better insight into tumorigenesis of lung adenocar-
cinoma initiated by variant FA repair genes and how this
is modified by exposure to cigarette smoke.
Though patients with FA are not more susceptible to
lung cancer, somatic inactivation of the FA pathway has
been observed in lung cancers [46]. Promoter hyperme-
thylation of FANCF occurs in a significant proportion of
lung cancer patients and is a significant predictor of
poor survival [47]. This finding provides support for the
biological plausibility of involvement of FA genes in lung
cancer development. However, in considering whether
our findings represent a true association between the
SNPs of the FA genes and lung adenocarcinoma, the
most important issue is the interpretation of the identi-
fied association between the SNPs and the trait. The
present study used a candidate gene approach based on
SNPs locating in the genes of the FA pathway. Because
the SNPs analyzed do not affect amino acid coding and
therefore probably do not directly affect protein func-
tion, the observed associations between cancer risk and
SNPs should be interpreted as the presence of LD
Fig. 3 Interaction between functionally-related Fanconi anemia (FA) genes in determining lung adenocarcinoma risk in males (a) and females (b),
assessed by stratified analysis. Lung adenocarcinoma risk associated with the number of high-risk genotypes of FA genes in males or females
stratified by genotypes of specific functionally-interacting FA genes. See the Results section for details of the putative mechanisms involved in
these interactions. The numbers in parenthesis in each stratum are the number of cases/number of controls in this stratum
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in functional polymorphism) or in regulatory regions
(affecting the expression of these genes). Furthermore,
genetic heterogeneity is less of a concern in Taiwan
than in the United States [31], and as a result, poten-
tial bias due to population stratification is less likely
to be significant in our study, and the probability that
the functional variants targeted by the same SNPs of
individual FA genes are different in cases and controls
due to differences in the genetic background of the two
groups is small. However, we recognize that sequencing of
the entire gene and promoter region is the definitive ap-
proach to identify all important sequence variants and that
a large-scale evaluation of these variants and functional
assessments are needed to address this question.
We previously proposed a hide-then-hit model [40],
suggesting that the probability of manifesting the
tumorigenic phenotype associated with low-penetrance
alleles (such as SNPs) might depend on a joint effectbetween these polymorphic alleles and endogenous or
exogenous risk factors. Our finding that tumorigenesis
of lung adenocarcinoma due to FA genes was influenced
by a cigarette smoke-related risk factor (Fig. 2) is con-
sistent with this hypothesis. This finding suggests that,
in subjects exposed to a greater cumulative amount of
cigarette smoke, the lung cells are subjected to a larger
amount of cross-linking agents and subsequently have a
higher potential to develop lung adenocarcinoma if they
have a suboptimal ability to maintain genomic stability
because of harboring variant FA genes. The combined
effect of FA genes and smoking-related risk factors lead-
ing to an increased risk of lung adenocarcinoma can also
explain the tissue specificity if smoking or passive smok-
ing creates a selective micro-environment beneficial for
lung cells with abnormal FA function.
On the other hand, the hide-then-hit model [40],
which suggests that a different range of disease pheno-
types is caused by mutated forms or hypomorphic/
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plied to explain the lack of lung cancer predisposition in
FA patients. Because the FA genes are essential, sub-
optimal function due to mutated alleles of these genes
would predispose cells to a high degree of genomic in-
stability [39], leading to a severe decrease in proliferation
and apoptosis caused by cell-cycle checkpoint, such as
p53, thus reducing the likelihood that additional muta-
tions will occur and allowing tumor formation. The im-
portance of these findings is that escaping checkpoint
surveillance is a critical element in the pathogenesis of
cancer resulting from defective DNA repair mechanisms,
such as the FA pathway, and it is probable that only mild
phenotypic defects, such as slightly increased genomic
instability resulting from suboptimal repair capacity
associated with SNPs of FA genes, could meet this
“hide-then-hit” requirement [40]. Our suggestion is in
line with findings in cell culture and an animal model.
Following DNA damage, embryonic fibroblasts from
Fancd2(−/−) mice, but not Fancd2(−/−)/p53(−/−) mice,
arrest [48]. Furthermore, loss of p53 (i.e., heterozygosity
for p53) significantly accelerated epithelial tumor forma-
tion in Fancd2 knockout mice. Interestingly, when
Fancd2 mutant mice were crossed to mice with a null
mutation in p53, lung adenocarcinomas were observed
in these Fancd2(−/−)/p53(+/−) mice, but rarely in
p53(+/−) mice, supporting the involvement of FA genes
in lung cancer development.
The multigenic approach used in our study led to sev-
eral joint effects within FA complexes being identified as
significant in determining cancer risk. Recently, evidence
has emerged for the cooperative involvement of different
genes in disease etiology and cancer development. The
combination of heterozygous abnormalities in different,
but functionally related, genes is known to play a causal
role in the pathogenesis of certain genetic syndromes
[49]. Evidence for an increased level of genomic instabil-
ity due to a combined effect of genes belonging to a
common DNA repair pathway has been provided in a
mouse model [50]. At the cellular level, the amount of
DNA damage present in lymphoblastoid cell lines from
healthy persons not exposed to a carcinogen is directly
related to the number of variant alleles of genes involved
in the DNA repair pathway [51]. Further support for a
joint carcinogenic effect comes from observational stud-
ies. For instance, there is a trend to increased risk of
developing breast cancer in women harboring a greater
number of putative high-risk genotypes of major
estrogen-metabolizing and DNA repair genes [52].
Conclusion
In the present study, we addressed the issue of gene-
gene interactions by examining joint effects among FA
genes in relation to lung adenocarcinoma risk, but thenovelty of our analysis is that it also tested these associa-
tions based on interactions known to operate among FA
proteins at the molecular level. To the best of our know-
ledge, no epidemiological study has used this approach
to examine gene-gene interactions in the FA pathway
leading to cancer susceptibility. Certainly, given the
number of comparisons and the sample size of the
present study, the conclusions should be interpreted
with caution and confirmed by other studies based on a
larger sample size. However, our consistent identification
of specific joint effects of FA genes within FA complexes
leading to an increased risk of lung adenocarcinomas in
both males and females provides support for a role of
FA genes in determining lung adenocarcinoma sus-
ceptibility. Finally, the definition of FA genes in lung
tumorigenesis is also of clinical importance. Platinum
chemotherapeutic agents are used to treat a broad
range of malignant diseases, including lung cancer,
and alterations of DNA repair processes are known to
be critical in mediating platinum resistance [53]. Because
platinum forms DNA crosslinks to kill tumor cells, we are
currently examining whether genetic polymorphism of FA
genes identified as important in determining cancer risk is
also associated with individual susceptibility to platinum
chemotherapy in lung cancer treatment.
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